PAVM PAVmed Inc
Price (delayed)
$0.7547
Market cap
$12.67M
P/E Ratio
0.23
Dividend/share
N/A
EPS
$3.3
Enterprise value
$43.34M
PAVmed Inc. is a highly differentiated, multiproduct medical device company employing a unique business model designed to advance innovative products to commercialization much more rapidly and with significantly less capital
Highlights
The net income has surged by 162% year-on-year and by 64% since the previous quarter
The EPS has soared by 136% year-on-year
PAVM's quick ratio has dropped by 92% year-on-year but it has surged by 50% since the previous quarter
PAVM's gross margin has surged by 62% year-on-year but it is down by 4.9% since the previous quarter
Key stats
What are the main financial stats of PAVM
Market
Valuations
Earnings
Shares outstanding
16.79M
Market cap
$12.67M
Enterprise value
$43.34M
Price to earnings (P/E)
0.23
Price to book (P/B)
N/A
Price to sales (P/S)
2.44
EV/EBIT
1.09
EV/EBITDA
1.06
EV/Sales
14.47
Revenue
$3M
Gross profit
-$1.85M
Operating income
-$44.49M
Net income
$39.79M
EBIT
$39.84M
EBITDA
$41.04M
Free cash flow
-$33.61M
Per share
Balance sheet
Liquidity
EPS
$3.3
EPS diluted
$0.5
Free cash flow per share
-$3.47
Book value per share
-$0.23
Revenue per share
$0.31
TBVPS
$3.17
Total assets
$30.66M
Total liabilities
$37.69M
Debt
$31.86M
Equity
-$2.5M
Working capital
-$33.28M
Debt to equity
-12.77
Current ratio
0.06
Quick ratio
0.03
Net debt/EBITDA
0.75
Margins
Efficiency
Dividend
EBITDA margin
1,370.4%
Gross margin
-61.6%
Net margin
1,328.6%
Operating margin
-1,485.4%
Return on assets
92.7%
Return on equity
N/A
Return on invested capital
234.3%
Return on capital employed
N/A
Return on sales
1,330.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PAVM stock price
How has the PAVmed stock price performed over time
Intraday
-1.99%
1 week
6.3%
1 month
-5.66%
1 year
-59.21%
YTD
20.27%
QTD
4.62%
Financial performance
How have PAVmed's revenue and profit performed over time
Revenue
$3M
Gross profit
-$1.85M
Operating income
-$44.49M
Net income
$39.79M
Gross margin
-61.6%
Net margin
1,328.6%
The net income has surged by 162% year-on-year and by 64% since the previous quarter
The net margin has soared by 151% YoY and by 120% from the previous quarter
PAVM's gross margin has surged by 62% year-on-year but it is down by 4.9% since the previous quarter
PAVM's gross profit has surged by 54% year-on-year and by 22% since the previous quarter
Growth
What is PAVmed's growth rate over time
Valuation
What is PAVmed stock price valuation
P/E
0.23
P/B
N/A
P/S
2.44
EV/EBIT
1.09
EV/EBITDA
1.06
EV/Sales
14.47
The EPS has soared by 136% year-on-year
The equity has surged by 95% year-on-year and by 49% since the previous quarter
The stock's price to sales (P/S) is 26% less than its last 4 quarters average of 3.3
PAVmed's revenue has decreased by 26% from the previous quarter but it has increased by 22% YoY
Efficiency
How efficient is PAVmed business performance
PAVM's return on assets has surged by 168% year-on-year and by 121% since the previous quarter
The ROS has soared by 151% year-on-year and by 120% since the previous quarter
The company's return on invested capital has surged by 136% YoY and by 17% QoQ
Dividends
What is PAVM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PAVM.
Financial health
How did PAVmed financials performed over time
The total assets is 19% less than the total liabilities
PAVM's quick ratio has dropped by 92% year-on-year but it has surged by 50% since the previous quarter
PAVmed's current ratio has shrunk by 87% YoY
The equity has surged by 95% year-on-year and by 49% since the previous quarter
PAVM's debt to equity has dropped by 78% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.